Atlas Trials

A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

Clinical trial NCT00501696 · COMPLETED

Trial details

NCT number
NCT00501696
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2007-02-01
Primary completion
2007-11-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.